Bottlebrush Block Copolymer Nanoparticle Surface Topography Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nanoparticle-based drug delivery systems face limitations due to rapid blood clearance and low drug delivery efficiency, largely attributed to the rapid opsonization and clearance by the mononuclear phagocytosis system, and the challenge of controlling the surface topography of polymeric nanoparticles.
Innovation Solution
The development of a method to precisely tailor the surface topography of polymeric nanoparticles by tuning the architecture of shape-persistent amphiphilic bottlebrush block copolymer (BBCP) building blocks, allowing for controlled nanoparticle formation and surface topography without altering the PEG conformation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If PEG coating is applied to reduce opsonization and clearance, then blood circulation time is improved, but cell uptake is reduced
Solution Approach 1:
The patent applies local quality by creating distinct regions on the nanoparticle surface with different PEG chain characteristics. The inner core region has densely packed PEG chains for stealth properties, while the outer shell region has more loosely packed chains that allow cell interactions, thus achieving both prolonged circulation and maintained cell uptake
Solution Approach 2:
The patent introduces asymmetry by designing a core-shell structure where the inner core and outer shell have different PEG chain densities and conformations. This asymmetric architecture allows the nanoparticle to exhibit different functional properties in different regions, resolving the contradiction between stealth and cell uptake
2Productivity
If surface topography is modified to enhance cell uptake, then cellular internalization is improved, but control over polymeric nanoparticle surface topography remains difficult
Solution Approach 1:
The patent applies parameter changes by systematically varying PEG chain length, grafting density, and molecular weight to precisely control surface topography parameters such as brush height, chain spacing, and surface roughness, thereby achieving enhanced cell uptake through controlled manufacturing parameters
3Object-affected harmful factors
If PEG chain density is increased to reduce protein adsorption, then stealth properties are improved, but cell uptake is further reduced
Solution Approach 1:
The patent applies local quality by creating spatial variation in PEG chain density across the nanoparticle surface. The inner core maintains high PEG density for protein repulsion, while the outer shell has reduced density to permit cell membrane interactions, thus simultaneously achieving anti-fouling and cell uptake properties
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the creation of nanoparticles with enhanced circulation half-lives and improved cell uptake, while minimizing protein adsorption, thereby overcoming the limitations of conventional nanoparticle drug delivery systems.
Implementation Method 1
coating the surface with a dense layer of poly(ethylene glycol) (PEG), which reduces opsonization and subsequent clearance by the mononuclear phagocytosis system via steric repulsion
Implementation Method 2
the same characteristic inherently reduces their uptake into cells
Data Source
AI summary
A method to precisely tailor the surface topography of polymeric nanoparticles having bound thereto polyalkylene oxide, based on tuning the architecture of shape-persistent amphiphilic bottlebrush block copolymer (BBCP) building blocks, has been developed. It was demonstrated that nanoparticle formation and surface topography can be controlled by systematically changing structural parameters of BBCP architecture. The surface topography of PEGylated nanoparticles (nanoparticles having PEO or PEG covalently bound thereto) significantly affects their biological performance.